MetLife Investment Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20,543
| Closed | -$954K | – | 3022 |
|
|
2023
Q2 | $954K | Buy |
20,543
+1,692
| +9% | +$78.6K | 0.01% | 1295 |
|
|
2023
Q1 | $540K | Hold |
18,851
| – | – | ﹤0.01% | 1591 |
|
|
2022
Q4 | $588K | Buy |
18,851
+2,930
| +18% | +$91.4K | ﹤0.01% | 1536 |
|
|
2022
Q3 | $323K | Hold |
15,921
| – | – | ﹤0.01% | 1954 |
|
|
2022
Q2 | $247K | Buy |
15,921
+6,450
| +68% | +$100K | ﹤0.01% | 2164 |
|
|
2022
Q1 | $181K | Buy |
9,471
+3,377
| +55% | +$64.6K | ﹤0.01% | 2408 |
|
|
2021
Q4 | $154K | Buy |
+6,094
| New | +$154K | ﹤0.01% | 2211 |
|